HSP105 prevents depression-like behavior by increasing hippocampal brain-derived neurotrophic factor levels in mice

Science Advances

Volumn 3, Issue 5, 2017, Pages

  Hashikawa, Naoya ^a   Utaka, Yuta ^a   Ogawa, Takumi ^a   Tanoue, Ryo ^a   Morita, Yuna ^a   Yamamoto, Sayumi ^a   Yamaguchi, Satoru ^a   Kayano, Masafumi ^b   Zamami, Yoshito ^b,c   Hashikawa Hobara, Narumi ^a  

^a OKAYAMA UNIVERSITY OF SCIENCE   (Japan)

^b OKAYAMA UNIVERSITY   (Japan)

^c UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CULTURE; CELL PROLIFERATION; MAMMALS; PROTEINS;

BRAIN-DERIVED NEUROTROPHIC FACTORS; HEAT SHOCK PROTEIN; HIPPOCAMPAL CELLS; HIPPOCAMPAL NEUROGENESIS; MOLECULAR MECHANISM; NEUROLOGICAL DISEASE; NEUROTROPHIC FACTORS; ORAL ADMINISTRATION;

BRAIN;

BRAIN DERIVED NEUROTROPHIC FACTOR; BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; CARBAZOLE DERIVATIVE; DITERPENE; HEAT SHOCK PROTEIN 110; HSP105 PROTEIN, MOUSE; INDOLE ALKALOID; STAUROSPORINE AGLYCONE; TEPRENONE;

ANIMAL; ANIMAL BEHAVIOR; BIOSYNTHESIS; CELL LINE; DEPRESSION; DRUG EFFECT; GENE EXPRESSION REGULATION; HIPPOCAMPUS; MALE; MENTAL STRESS; METABOLISM; MOUSE; PATHOLOGY;

ANIMALS; BEHAVIOR, ANIMAL; BRAIN-DERIVED NEUROTROPHIC FACTOR; CARBAZOLES; CELL LINE; DEPRESSION; DITERPENES; GENE EXPRESSION REGULATION; HIPPOCAMPUS; HSP110 HEAT-SHOCK PROTEINS; INDOLE ALKALOIDS; MALE; MICE; RECEPTOR, TRKB; STRESS, PSYCHOLOGICAL;

EID: 85030255038     PISSN: None     EISSN: 23752548     Source Type: Journal    
DOI: 10.1126/sciadv.1603014     Document Type: Article

References (45)

1. F. U. Hartl, Heat shock proteins in protein folding and membrane translocation. Semin. Immunol. 1, 5-16 (1991).
2. J. K. Fink, P. Hedera, Hereditary spastic paraplegia: Genetic heterogeneity and genotype-phenotype correlation. Semin. Neurol. 19, 301-309 (1999).
3. M. J. Vos, J. Hageman, S. Carra, H. H. Kampinga, Structural and functional diversities between members of the human HSPB, HSPH, HSPA, and DNAJ chaperone families. Biochemistry 47, 7001-7011 (2008).
4. G. Morrow, R. M. Tanguay, Drosophila melanogaster Hsp22: A mitochondrial small heat shock protein influencing the aging process. Front. Genet. 6, 1026 (2015).
5. M. Katsuno, C. Sang, H. Adachi, M. Minamiyama, M. Waza, F. Tanaka, M. Doyu, G. Sobue, Pharmacological induction of heat-shock proteins alleviates polyglutamine-mediated motor neuron disease. Proc. Natl. Acad. Sci. U.S.A. 102, 16801-16806 (2005).
6. P. J. Muchowski, J. L. Wacker, Modulation of neurodegeneration by molecular chaperones. Nat. Rev. Neurosci. 6, 11-22 (2005).
7. Y. Kobayashi, G. Sobue, Protective effect of chaperones on polyglutamine diseases. Brain Res. Bull. 56, 165-168 (2001).
8. T. Rajapandi, L. E. Greene, E. Eisenberg, The molecular chaperones Hsp90 and Hsc70 are both necessary and sufficient to activate hormone binding by glucocorticoid receptor. J. Biol. Chem. 275, 22597-22604 (2000).
9. B. L. Hylander, X. Chen, P. C. F. Graf, J. R. Subjeck, The distribution and localization of hsp110 in brain. Brain Res. 869, 49-55 (2000).
10. H. Quraishi, S. J. Rush, I. R. Brown, Expression of mRNA species encoding heat shock protein 90 (hsp90) in control and hyperthermic rabbit brain. J. Neurosci. Res. 43, 335-345 (1996).
11. I. Sotiropoulos, J. Silva, T. Kimura, A. J. Rodrigues, P. Costa, O. F. X. Almeida, N. Sousa, A. Takashima, Female hippocampus vulnerability to environmental stress, a precipitating factor in Tau aggregation pathology. J. Alzheimers Dis. 43, 763-774 (2015).
12. T. Hirakawa, K. Rokutan, T. Nikawa, K. Kishi, Geranylgeranylacetone induces heat shock proteins in cultured guinea pig gastric mucosal cells and rat gastric mucosa. Gastroenterology 111, 345-357 (1996).
13. K. Yamagami, Y. Yamamoto, Y. Ishikawa, K. Yonezawa, S. Toyokuni, Y. Yamaoka, Effects of geranyl-geranyl-acetone administration before heat shock preconditioning for conferring tolerance against ischemia-reperfusion injury in rat livers. J. Lab. Clin. Med. 135, 465-475 (2000).
14. M. Fujiki, H. Kobayashi, T. Abe, K. Ishii, Astroglial activation accompanies heat shock protein upregulation in rat brain following single oral dose of geranylgeranylacetone. Brain Res. 991, 254-257 (2003).
15. S. Uchida, M. Fujiki, Y. Nagai, T. Abe, H. Kobayashi, Geranylgeranylacetone, a noninvasive heat shock protein inducer, induces protein kinase C and leads to neuroprotection against cerebral infarction in rats. Neurosci. Lett. 396, 220-224 (2006).
16. M. Joëls, H. Karst, D. Alfarez, V. M. Heine, Y. Qin, E. van Riel, M. Verkuyl, P. J. Lucassen, H. J. Krugers, Effects of chronic stress on structure and cell function in rat hippocampus and hypothalamus. Stress 7, 221-231 (2004).
17. O. Berton, E. J. Nestler, New approaches to antidepressant drug discovery: Beyond monoamines. Nat. Rev. Neurosci. 7, 137-151 (2006).
18. G. Ramírez-Rodríguez, H. Babu, F. Klempin, O. Krylyshkina, V. Baekelandt, R. Gijsbers, Z. Debyser, R. W. Overall, Z. Nicola, K. Fabel, G. Kempermann, The a crystallin domain of small heat shock protein b8 (Hspb8) acts as survival and differentiation factor in adult hippocampal neurogenesis. J. Neurosci. 33, 5785-5796 (2013).
19. M. E. Toth, S. Gonda, L. Vigh, M. Santha, Neuroprotective effect of small heat shock protein, Hsp27, after acute and chronic alcohol administration. Cell Stress Chaperones 15, 807-817 (2010).
20. O. Berton, C. A. McClung, R. J. Dileone, V. Krishnan, W. Renthal, S. J. Russo, D. Graham, N. M. Tsankova, C. A. Bolanos, M. Rios, L. M. Monteggia, D. W. Self, E. J. Nestler, Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress. Science 311, 864-868 (2006).
21. R. S. Duman, L. M. Monteggia, A neurotrophic model for stress-related mood disorders. Biol. Psychiatry 59, 1116-1127 (2006).
22. C.-g. Shi, L.-m. Wang, Y. Wu, P. Wang, Z.-j. Gan, K. Lin, L.-x. Jiang, Z.-q. Xu, M. Fan, Intranasal administration of nerve growth factor produces antidepressant-like effects in animals. Neurochem. Res. 35, 1302-1314 (2010).
23. J. H. Kordower, O. Isacson, D. F. Emerich, Cellular delivery of trophic factors for the treatment of Huntington's disease: Is neuroprotection possible? Exp. Neurol. 159, 4-20 (1999).
24. Y. Shirayama, A. C.-H. Chen, S. Nakagawa, D. S. Russell, R. S. Duman, Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression. J. Neurosci. 22, 3251-3261 (2002).
25. C. L. Raison, A. S. Borisov, S. D. Broadwell, L. Capuron, B. J. Woolwine, I. M. Jacobson, C. B. Nemeroff, A. H. Miller, Depression during pegylated interferon-alpha plus ribavirin therapy: Prevalence and prediction. J. Clin. Psychiatry 66, 41-48 (2005).
26. T. Otsubo, H. Miyaoka, K. Kamijima, M. Onuki, M. Ishii, K. Mitamura, Depression during interferon therapy in chronic hepatitis C patients: A prospective study. Seishin Shinkeigaku Zasshi 99, 101-127 (1997).
27. H. Yasuda, H. Shichinohe, S. Kuroda, T. Ishikawa, Y. Iwasaki, Neuroprotective effect of a heat shock protein inducer, geranylgeranylacetone in permanent focal cerebral ischemia. Brain Res. 1032, 176-182 (2005).
28. M. Yoneyama, N. Iwamoto, R. Nagashima, C. Sugiyama, K. Kawada, N. Kuramoto, M. Shuto, K. Ogita, Altered expression of heat shock protein 110 family members in mouse hippocampal neurons following trimethyltin treatment in vivo and in vitro. Neuropharmacology 55, 693-703 (2008).
29. M. Fujiki, T. Hikawa, T. Abe, S. Uchida, M. Morishige, K. Sugita, H. Kobayashi, Role of protein kinase C in neuroprotective effect of geranylgeranylacetone, a noninvasive inducing agent of heat shock protein, on delayed neuronal death caused by transient ischemia in rats. J. Neurotrauma 23, 1164-1178 (2006).
30. D.-I. Sinn, K. Chu, S.-T. Lee, E.-C. Song, K.-H. Jung, E.-H. Kim, D.-K. Park, K.-M. Kang, M. Kim, J.-K. Roh, Pharmacological induction of heat shock protein exerts neuroprotective effects in experimental intracerebral hemorrhage. Brain Res. 1135, 167-176 (2007).
31. Z. Zhao, A. I. Faden, D. J. Loane, M. M. Lipinski, B. Sabirzhanov, B. A. Stoica, Neuroprotective effects of geranylgeranylacetone in experimental traumatic brain injury. J. Cereb. Blood Flow Metab. 33, 1897-1908 (2013).
32. T. Hatayama, N. Yamagishi, E. Minobe, K. Sakai, Role of hsp105 in protection against stress-induced apoptosis in neuronal PC12 cells. Biochem. Biophys. Res. Commun. 288, 528-534 (2001).
33. X. Tao, S. Finkbeiner, D. B. Arnold, A. J. Shaywitz, M. E. Greenberg, Ca2+ influx regulates BDNF transcription by a CREB family transcription factor-dependent mechanism. Neuron 20, 709-726 (1998).
34. F. Zheng, X. Zhou, C. Moon, H. Wang, Regulation of brain-derived neurotrophic factor expression in neurons. Int. J. Physiol. Pathophysiol. Pharmacol. 4, 188-200 (2012).
35. P. Tapley, F. Lamballe, M. Barbacid, K252a is a selective inhibitor of the tyrosine protein kinase activity of the trk family of oncogenes and neurotrophin receptors. Oncogene 7, 371-381 (1992).
36. T. Mikuriya, K. Sugahara, K. Sugimoto, M. Fujimoto, T. Takemoto, M. Hashimoto, Y. Hirose, H. Shimogori, N. Hayashida, S. Inouye, A. Nakai, H. Yamashita, Attenuation of progressive hearing loss in a model of age-related hearing loss by a heat shock protein inducer, geranylgeranylacetone. Brain Res. 1212, 9-17 (2008).
37. C. Sakamoto, K. Ogoshi, K. Saigenji, R. Narisawa, H. Nagura, T. Mine, M. Tada, E. Umegaki, T. Maekawa, R. Maekawa, K. Maeda, Comparison of the effectiveness of geranylgeranylacetone with cimetidine in gastritis patients with dyspeptic symptoms and gastric lesions: A randomized, double-blind trial in Japan. Digestion 75, 215-224 (2007).
38. K. Sumigawa, K. Nakao, T. Iwama, T. Ohgoh, T. Chiba, Acute toxicity test of tetraprenylacetone in rats and mice. Prog. Med. 3, 1053-1057 (1983).
39. B. Jiang, Z. Xiong, J. Yang, W. Wang, Y. Wang, Z.-L. Hu, F. Wang, J.-G. Chen, Antidepressant-like effects of ginsenoside Rg1 are due to activation of the BDNF signalling pathway and neurogenesis in the hippocampus. Br. J. Pharmacol. 166, 1872-1887 (2012).
40. N. Hashikawa-Hobara, T. Ogawa, Y. Sakamoto, Y. Matsuo, M. Ogawa, Y. Zamami, N. Hashikawa, Calcitonin gene-related peptide pre-administration acts as a novel antidepressant in stressed mice. Sci. Rep. 5, 12559 (2015).
41. L. Steru, R. Chermat, B. Thierry, P. Simon, The tail suspension test: A new method for screening antidepressants in mice. Psychopharmacology 85, 367-370 (1985).
42. S. Uchida, K. Hara, A. Kobayashi, M. Fujimoto, K. Otsuki, H. Yamagata, T. Hobara, N. Abe, F. Higuchi, T. Shibata, S. Hasegawa, S. Kida, A. Nakai, Y. Watanabe, Impaired hippocampal spinogenesis and neurogenesis and altered affective behavior in mice lacking heat shock factor 1. Proc. Natl. Acad. Sci. U.S.A. 108, 1681-1686 (2011).
43. A. Recober, A. Kuburas, Z. Zhang, J. A. Wemmie, M. G. Anderson, A. F. Russo, Role of calcitonin gene-related peptide in light-aversive behavior: Implications for migraine. J. Neurosci. 29, 8798-8804 (2009).
44. T. Sakaeda, A. Tamon, K. Kadoyama, Y. Okuno, Data mining of the public version of the FDA Adverse Event Reporting System. Int. J. Med. Sci. 10, 796-803 (2013).
45. M. Fujimoto, T. Higuchi, K. Hosomi, M. Takada, Association between statin use and cancer: Data mining of a spontaneous reporting database and a claims database. Int. J. Med. Sci. 12, 223-233 (2015).